Skip to content
Clear Cards Online

The Zimbabwean Government Declines ‘Lopsided’ American Healthcare Assistance Deal Because of Information Apprehensions

Medical aid illustration
The offered American financial assistance would have supported initiatives for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has turned down a substantial American health deal valued at $367m (272 million pounds) over five years due to Washington's demand for sensitive information.

This move came to light after a government memo from December was leaked, which showed President Emmerson Mnangagwa believed the deal was "skewed".

An official spokesperson later stated that the United States was requesting health data for scientific study and profit while refused to share the resulting advantages from future treatments.

"We must now begin the challenging and unfortunate task of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the US had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has called for further negotiations to reach a agreement suitable to both sides so the nation's critical HIV treatment initiative can continue.

Wider Context

This development comes after a comparable situation in Kenya, where a high court halted a related health funding agreement following legal challenges were raised about the safety of Kenyans' health data.

Since returning to the presidency recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).

USAID had overseen aid for the US government, but Trump argued its spending was "wasteful" and his government was pursuing direct bilateral deals to enhance openness and accountability.

As per reports, Sixteen nations in Africa have so far signed similar agreements, constituting over $18.3bn in new funding.

Specifics of the Rejected Deal

The money for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"It is our view this cooperation would have delivered significant advantages for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy through American-funded initiatives," Tremont commented.

However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".

"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, with no equivalent promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that provided information," he stated.

"Effectively, our country would provide the raw materials for scientific discovery with no certainty that the resulting innovations would be available to our citizens should a new health crisis emerge."

Sovereignty and International Frameworks

He also said that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were upending frameworks previously set up via the global organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to deal with future pandemics.

"This framework is designed to ensure that when a nation provides its information, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to create them."

These objections regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We encourage ongoing dialogue with our US partners on how subsequent co-operation could be arranged in a manner that honours the independence and interests of both nations."

Health Experts Response

Medical experts expressed it understood the official position, but suggested that negotiations should continue considering much of the nation's Aids initiatives depended on foreign aid.

"If specific concerns arise, such as those involving information security or agreement terms, these can frequently be addressed via technical clarification and mutually agreed protections," the group added.

The situation underscores the continuing tensions between accepting vital foreign assistance and safeguarding a country's data in an ever more data-driven world.

About the author

William Bailey

A digital marketing strategist specializing in networking technologies and personal branding with over a decade of industry experience.

Clear Cards Online

Type to search articles.